Fellows' Journal Club


Wednesday, Thursday
Noon-1:00 PM (alternates with Tumor Board)
11th Floor Mid-Campus Center, North Conference Room

2020-2021 Academic Year

Date Speaker Title Download
Apr 7, 2021 Alice Zhou Gastrointestinal Cancer
Atezolizumab Plus Bevacizumab in Unresectable Hepatocellular Carcinoma
➤ PubMed
Bindiya Patel Pembrolizumab in Microsatellite-Instability-High Advanced Colorectal Cancer ➤ PubMed
Apr 21, 2021 Miriam Jacobs Genitourinary Cancers
Lenvatinib Plus Pembrolizumab or Everolimus for Advanced Renal Cell Carcinoma
➤ PubMed
Dhruv Bansal Enfortumab Vedotin in Previously Treated Advanced Urothelial Carcinoma ➤ PubMed
Apr 29, 2021 Vanessa Eulo Breast Cancer
Efficacy of Margetuximab Vs Trastuzumab in Patients With Pretreated ERBB2-Positive Advanced Breast Cancer: A Phase 3 Randomized Clinical Trial
➤ PubMed
Gradon Nielsen Pembrolizumab for Early Triple-Negative Breast Cancer ➤ PubMed
May 6, 2021 David Russler-Germain Melanoma
Five-Year Analysis of Adjuvant Dabrafenib Plus Trametinib in Stage III Melanoma
➤ PubMed
Michael Kramer Fecal Microbiota Transplant Promotes Response in Immunotherapy-Refractory Melanoma Patients ➤ PubMed
May 13, 2021 Raya Saba Benign Hematology / Myeloma
Long-Term Outcomes With Emicizumab Prophylaxis for Hemophilia A With or Without FVIII Inhibitors From the HAVEN 1-4 Studies
➤ PubMed
Zach Crees Idecabtagene Vicleucel in Relapsed and Refractory Multiple Myeloma ➤ PubMed
May 25, 2021 Michael Slade Thrombosis / Bleeding Disorders
Fahrettin Covut
Jun 1, 2021 Lauren Shea Lymphoma
Mary-Kate Malecek
Jun 9, 2021 Ryan Day Leukemia
Scott Goldsmith
Jun 16, 2021 Andrew Young Gyn Onc Malignancies
Michael Iglesia
Jun 24, 2021 Jing Xi Lung Cancer
Whitney Hensing